Viewing Study NCT00121303


Ignite Creation Date: 2025-12-24 @ 7:36 PM
Ignite Modification Date: 2026-01-25 @ 12:07 AM
Study NCT ID: NCT00121303
Status: COMPLETED
Last Update Posted: 2016-09-20
First Post: 2005-07-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cytarabine and Daunorubicin With or Without Gemtuzumab Ozogamicin in Treating Older Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult acute monocytic leukemia (M5b) View
None adult erythroleukemia (M6a) View
None adult pure erythroid leukemia (M6b) View
None adult acute megakaryoblastic leukemia (M7) View
None adult acute myeloblastic leukemia with maturation (M2) View
None adult acute myeloblastic leukemia without maturation (M1) View
None adult acute myelomonocytic leukemia (M4) View
None adult acute monoblastic leukemia (M5a) View
None refractory anemia with excess blasts in transformation View
None refractory anemia with excess blasts View
None secondary acute myeloid leukemia View
None untreated adult acute myeloid leukemia View
None de novo myelodysplastic syndromes View
None adult acute minimally differentiated myeloid leukemia (M0) View
None adult acute myeloid leukemia with 11q23 (MLL) abnormalities View
None adult acute myeloid leukemia with inv(16)(p13;q22) View
None adult acute myeloid leukemia with t(16;16)(p13;q22) View
None adult acute myeloid leukemia with t(8;21)(q22;q22) View
None secondary myelodysplastic syndromes View